Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MLH1 |
Variant | C233R |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | MLH1 C233R lies within the ATPase domain of the Mlh1 protein (PMID: 22753075). C233R has been identified in sequencing studies (PMID: 34513290), but has not been biochemically characterized and therefore, its effect on Mlh1 protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | |
Category Variants Paths |
MLH1 mutant MLH1 C233R |
Transcript | NM_000249.4 |
gDNA | chr3:g.37014451T>C |
cDNA | c.697T>C |
Protein | p.C233R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000249 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001258271.1 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001354628.2 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_000249.3 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_000249.4 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001354628.1 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001258271.2 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001258271 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001354630.2 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
NM_001354630.1 | chr3:g.37014451T>C | c.697T>C | p.C233R | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
MLH1 mutant | endometrial carcinoma | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MLH1 result in Lynch syndrome, which is associated with increased risk of developing endometrial carcinoma (NCCN.org). | detail... |
MLH1 mutant | ovarian cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MLH1 result in Lynch syndrome, which is associated with increased risk of ovarian cancer (NCCN.org). | detail... |
MLH1 mutant | stomach cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MLH1 result in Lynch syndrome, which is associated with increased risk of early onset of gastric cancer (NCCN.org). | detail... |
MLH1 mutant | small intestine adenocarcinoma | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing small bowel adenocarcinoma (NCCN.org). | detail... |
MLH1 mutant | rectum cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colorectal cancer (NCCN.org). | detail... |
MLH1 mutant | colon cancer | not applicable | N/A | Guideline | Risk Factor | Lynch syndrome results from germline mutations in DNA mismatch repair genes including MLH1, MSH2, MSH6, and PMS2, and is associated with increased risk of developing colon cancer (NCCN.org). | detail... |
MLH1 mutant | pancreatic cancer | not applicable | N/A | Guideline | Risk Factor | Germline mutations in MLH1 result in Lynch syndrome, which is associated with increased risk of developing pancreatic cancer (NCCN.org). | detail... |